PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

CAMH discovery of novel drug target may lead to better treatment for schizophrenia

2014-12-09
(Press-News.org) TORONTO - Dec. 9, 2014 (Toronto) - Scientists at the Centre for Addiction and Mental Health (CAMH) have identified a novel drug target that could lead to the development of better antipsychotic medications.

Dr. Fang Liu, Senior Scientist in CAMH's Campbell Family Mental Health Research Institute and Professor in the Department of Psychiatry, University of Toronto, and her team published their results online in the journal Neuron.

Current treatment for patients with schizophrenia involves taking medications that block or interfere with the action of the neurotransmitter dopamine, which acts on dopamine D2 receptors in the brain. However, because this D2-blocking action may cause unwanted side-effects, such as slow gait, stiffness and tremor, Dr. Liu and her team looked for new ways to interfere with the action of D2 receptors, without causing these side-effects.

Dr. Liu and colleagues showed that the D2 receptor could combine with a protein called the Disrupted-In-Schizophrenia (DISC1) protein. Then, they showed that levels of this combined protein were higher in post-mortem brain tissues of deceased patients with schizophrenia, suggesting it was associated with the illness. Delving even further, the researchers identified the regions where the two proteins bound together.

With this information, they were able to generate a peptide to disrupt the binding of the two proteins, speculating that it may reduce symptoms. In animal models of schizophrenia, they were able to demonstrate that this disruption led to antipsychotic effects, comparable to commonly used antipsychotic medications, but without their side-effects.

"The most exciting aspect of our finding is not the antipsychotic effect of this peptide, which all current antipsychotics have, but rather the possibility of a lack of the side-effects in humans compared to current medications", says Dr. Liu. "We hope that it will lead to a better treatment for schizophrenia patients who experience side-effects from current medications." These side-effects discourage some patients from taking their medications, which impacts recovery.

Schizophrenia is a chronic, often severe and disabling mental illness that affects one percent of the general population.

"Our future steps are to determine how this discovery can be translated into a novel treatment for patients as soon as possible," says Dr. Liu. "We are optimistic that our findings will lead to new and better options for treatment for schizophrenia."

INFORMATION:

This study was funded by the Canadian Institutes of Health Research (CIHR).



ELSE PRESS RELEASES FROM THIS DATE:

UBC team finds a glitch in hummingbird hovering

2014-12-09
Hummingbirds rely on their ability to hover in order to feed off the nectar of flowers. It's an incredible feat of flying requiring mind boggling visual processing power, but two University of British Columbia researchers found a glitch in the system, something the tiny birds are powerless to control. The researchers put hovering hummingbirds through a virtual reality experiment that showed the birds can't control their inflight response to some visual stimuli. In a laboratory flight arena, hummingbirds hovered around a plastic feeder while images were projected on ...

New technique could harvest more of the sun's energy

2014-12-09
As solar panels become less expensive and capable of generating more power, solar energy is becoming a more commercially viable alternative source of electricity. However, the photovoltaic cells now used to turn sunlight into electricity can only absorb and use a small fraction of that light, and that means a significant amount of solar energy goes untapped. A new technology created by researchers from Caltech, and described in a paper published online in the October 30 issue of Science Express, represents a first step toward harnessing that lost energy. Sunlight is ...

Ancient engravings rewrite human history

Ancient engravings rewrite human history
2014-12-09
An international team of scientists has discovered the earliest known engravings from human ancestors on a 400,000 year-old fossilised shell from Java. The discovery is the earliest known example of ancient humans deliberately creating pattern. "It rewrites human history," said Dr Stephen Munro from School of Archaeology and Anthropology at The Australian National University (ANU). "This is the first time we have found evidence for Homo erectus behaving this way," he said. The newly discovered engravings resemble the previously oldest-known engravings, which are ...

How pace of climate change will challenge ectotherms

2014-12-09
Animals that regulate their body temperature through the external environment may be resilient to some climate change but not keep pace with rapid change leading to potentially disastrous outcomes for biodiversity. A study by the University of Sydney and University of Queensland showed many animals can modify the function of their cells and organs to compensate for changes in the climate and have done so in the past, but the researchers warn that the current rate of climate change will outpace animals' capacity for compensation (or acclimation). The research has just ...

Common chemotherapy is not heart toxic in patients with BRCA1/2 mutations

2014-12-09
SAN ANTONIO -- Use of anthracycline-based chemotherapy, a common treatment for breast cancer, has negligible cardiac toxicity in women whose tumors have BRCA1/2 mutations -- despite preclinical evidence that such treatment can damage the heart. The findings, to be presented at the 2014 San Antonio Breast Cancer Symposium (SABCS), represent a unique effort between cardiologists and oncologists at Georgetown Lombardi Comprehensive Cancer Center and MedStar Heart & Vascular Institute in Washington to answer a vital clinical question. "Our study was prompted by evidence from ...

Three new Myriad studies highlighted at 2014 San Antonio Breast Cancer Symposium

2014-12-09
SALT LAKE CITY, Utah, Dec. 9, 2014 - Myriad Genetics, Inc. (NASDAQ: MYGN) today announced results from a new study that demonstrated the ability of the myRisk™ Hereditary Cancer test to detect 105 percent more mutations in cancer causing genes than conventional BRCA testing alone. The Company also presented two key studies in triple negative breast cancer (TNBC) that show the myChoice™ HRD test accurately predicted response to platinum-based therapy in patients with early-stage TNBC and that the BRACAnalysis® molecular diagnostic test significantly predicted ...

Temperature anomalies are warming faster than Earth's average

Temperature anomalies are warming faster than Earths average
2014-12-09
BLOOMINGTON, Ind. -- It's widely known that the Earth's average temperature has been rising. But research by an Indiana University geographer and colleagues finds that spatial patterns of extreme temperature anomalies -- readings well above or below the mean -- are warming even faster than the overall average. And trends in extreme heat and cold are important, said Scott M. Robeson, professor of geography in the College of Arts and Sciences at IU Bloomington. They have an outsized impact on water supplies, agricultural productivity and other factors related to human health ...

Warmer Pacific Ocean could release millions of tons of seafloor methane

Warmer Pacific Ocean could release millions of tons of seafloor methane
2014-12-09
Off the West Coast of the United States, methane gas is trapped in frozen layers below the seafloor. New research from the University of Washington shows that water at intermediate depths is warming enough to cause these carbon deposits to melt, releasing methane into the sediments and surrounding water. Researchers found that water off the coast of Washington is gradually warming at a depth of 500 meters, about a third of a mile down. That is the same depth where methane transforms from a solid to a gas. The research suggests that ocean warming could be triggering the ...

Long-term endurance training impacts muscle epigenetics

Long-term endurance training impacts muscle epigenetics
2014-12-09
A new study from Karolinska Institutet in Sweden shows that long-term endurance training in a stable way alters the epigenetic pattern in the human skeletal muscle. The research team behind the study, which is being published in the journal Epigenetics, also found strong links between these altered epigenetic patterns and the activity in genes controlling improved metabolism and inflammation. The results may have future implications for prevention and treatment of heart disease, diabetes and obesity. "It is well-established that being inactive is perilous, and that regular ...

Nanotechnology against malaria parasites

Nanotechnology against malaria parasites
2014-12-09
Malaria parasites invade human red blood cells; they then disrupt them and infect others. Researchers at the University of Basel and the Swiss Tropical and Public Health Institute (Swiss TPH) have now developed so-called nanomimics of host cell membranes that trick the parasites. This could lead to novel treatment and vaccination strategies in the fight against malaria and other infectious diseases. Their research results have been published in the scientific journal ACS Nano. For many infectious diseases no vaccine currently exists. In addition, resistance against ...

LAST 30 PRESS RELEASES:

Scientists can tell healthy and cancerous cells apart by how they move

Male athletes need higher BMI to define overweight or obesity

How thoughts influence what the eyes see

Unlocking the genetic basis of adaptive evolution: study reveals complex chromosomal rearrangements in a stick insect

Research Spotlight: Using artificial intelligence to reveal the neural dynamics of human conversation

Could opioid laws help curb domestic violence? New USF research says yes

NPS Applied Math Professor Wei Kang named 2025 SIAM Fellow

Scientists identify agent of transformation in protein blobs that morph from liquid to solid

Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss

Research identifies key enzyme target to fight deadly brain cancers

New study unveils volcanic history and clues to ancient life on Mars

Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome

Scientists probe the mystery of Titan’s missing deltas

Q&A: What makes an ‘accidental dictator’ in the workplace?

Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture

Study highlights gaps in firearm suicide prevention among women

People with medical debt five times more likely to not receive mental health care treatment

Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B

Rise in claim denial rates for cancer-related advanced genetic testing

Legalizing youth-friendly cannabis edibles and extracts and adolescent cannabis use

Medical debt and forgone mental health care due to cost among adults

Colder temperatures increase gastroenteritis risk in Rohingya refugee camps

Acyclovir-induced nephrotoxicity: Protective potential of N-acetylcysteine

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury

AERA announces winners of the 2025 Palmer O. Johnson Memorial Award

Mapping minds: The neural fingerprint of team flow dynamics

Patients support AI as radiologist backup in screening mammography

AACR: MD Anderson’s John Weinstein elected Fellow of the AACR Academy

Existing drug has potential for immune paralysis

Soft brainstem implant delivers high-resolution hearing

[Press-News.org] CAMH discovery of novel drug target may lead to better treatment for schizophrenia